Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Don't forget about IOV in Banff in November
View:
Post by askretka on Oct 01, 2023 11:14pm

Don't forget about IOV in Banff in November

Good summary Canadafan.

Although not as big a catalyst. I would add IOV conference in Banff as well. It was mentioned in fireside chat as well. Agenda is up. Couple interesting things in there including a talk about our Breast Cancer by Dr Heineman   
And CAR-T and Virus talk by one of researchers who worked with Dr. Vile on original mouse study. 


https://cumming.ucalgary.ca/research/immune-oncology-initiative/iovc-2023/scientific-agenda


Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Comment by fox7mf on Oct 02, 2023 9:00am
Catalyst for what? Creating shareholder value? Nah, that won't register a blip, nor will ESMO. The market has spoken, and no one believes Coffey & Co care about shareholder value, and no one believes they can partner or sell this. Prove the market wrong Matt.
Comment by Azzak34 on Oct 02, 2023 9:19am
Esmo will as they're releasing more results. I take your point though and am finding it difficult to argue. 
Comment by Lesalpes29 on Oct 02, 2023 9:52am
They have to prove they can deliver not only cheap PP and cheap options! Patience is key but for how long? GL
Comment by Buckhenry on Oct 02, 2023 9:56am
I'm concerned that if they eeeevvvveeeerrrr get bought out we may not get to enjoy  MC doing the fireside chat.  That would be just devastating knowing the impact they have made on the stock.  Oh well... please control be patient. 
Comment by Azzak34 on Oct 02, 2023 10:06am
What a dumb post. If we get bought out he can do as many fireside, roadside and bedside chats he wants. Try your hardest to not post dumb stuff.  
Comment by Buckhenry on Oct 02, 2023 10:27am
I bet the pharmaceutical companies love some of you folks on here.  You probably take blood pressure medication by the hand fulls daily. Your strung tighter than a guitar string. Learn to lighten up and poke fun. Will do wonders for your terrible disposition. Besides... there is nothing that can be said here to change the situation of this stock. 
Comment by Azzak34 on Oct 02, 2023 10:38am
I would imagine your Obsessive Repulsive Disorder meds ain't cheap either.  Just post something interesting. Not these bland, vague "dreamer" posts. They're boring AF. Give us something a bit deeper, dig in your banter box and hit us with it!!! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities